You have 9 free searches left this month | for more free features.

clofarabine

Showing 1 - 25 of 123

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia in Remission Trial in France (Fludarabine, Busulfan, ATG)

Not yet recruiting
  • Acute Myeloid Leukemia in Remission
  • Nantes, Loire Atlantique, France
  • +22 more
Jun 15, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in Boston (Antithymocyte Globulin,

Active, not recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Antithymocyte Globulin
  • Clofarabine
  • Boston, Massachusetts
  • +1 more
Jan 25, 2022

MDS, Secondary Acute Myeloid Leukemia (AML) Trial in United States (Clofarabine)

Completed
  • Myelodysplastic Syndromes
  • Secondary Acute Myeloid Leukemia (AML)
  • Clofarabine
  • Chicago, Illinois
  • +5 more
Mar 15, 2022

Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +6 more
  • clofarabine
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Clofarabine and Fludarabine Drug Exposure in Pediatric Bone

Completed
  • Hematologic Malignancies
  • +7 more
  • Clofarabine
  • Fludarabine Injection
  • San Francisco, California
    University of California, San Francisco
Sep 27, 2021

Disorder Related to Bone Marrow Transplantation, Leukemia, Transplantation Infection Trial in Houston (Fludarabine, Clofarabine,

Completed
  • Disorder Related to Bone Marrow Transplantation
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 18, 2021

Minimal Residual Disease, Leukemia, Lymphoblastic, Acute, Leukemia, Myelogenous, Acute Trial in Charlotte, Seattle (Clofarabine,

Terminated
  • Minimal Residual Disease
  • +2 more
  • Clofarabine
  • +3 more
  • Charlotte, North Carolina
  • +1 more
Oct 4, 2021

Langerhans Cell Histiocytosis Trial in Canada, United States (Clofarabine)

Active, not recruiting
  • Langerhans Cell Histiocytosis
  • Clofarabine
  • Phoenix, Arizona
  • +14 more
Mar 28, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoblastic Lymphoma Trial in Valhalla, Charlotte (Clofarabine,

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Valhalla, New York
  • +1 more
Oct 29, 2021

Acute Myeloid Leukemia, Pediatric Cancer Trial in Boston (Uproleselan, Fludarabine, Clofarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Pediatric Cancer
  • Boston, Massachusetts
  • +1 more
Oct 24, 2022

Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • +3 more
  • Allogeneic Bone Marrow Transplantation
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Myelogenous Leukemia, Acute Trial in Ramat Gan (Bisantrene, Fludarabine, Clofarabine)

Recruiting
  • Myelogenous Leukemia, Acute
  • Ramat Gan, Israel
    Chaim Sheba Medical Center
Sep 21, 2021

Leukemia Trial in Germany (Amsacrine, Clofarabine, Cyclophosphamide)

Active, not recruiting
  • Leukemia
  • Bielefeld, Germany
  • +13 more
May 16, 2022

Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage Trial in Houston (Clofarabine,

Recruiting
  • Acute Bilineal Leukemia
  • +7 more
  • Clofarabine
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Allogeneic Hematopoietic Stem Cell

Completed
  • Acute Lymphoblastic Leukemia in Remission
  • +6 more
  • Allogeneic Bone Marrow Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 15, 2021

Acute Myeloid Leukemia Trial in Singapore, United States (Cytarabine, Daunorubicin, Etoposide)

Completed
  • Acute Myeloid Leukemia
  • Palo Alto, California
  • +7 more
Aug 6, 2021

GVHD Trial in Nantes (drug, radiation, other)

Terminated
  • Graft Versus Host Disease
  • Nantes, France
    Nantes Uh
Jul 13, 2022

AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)

Recruiting
  • AML
  • +8 more
  • Clofarabine
  • +5 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 13, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia Trial in Houston (Clofarabine, Busulfan, Fludarabine)

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Clofarabine
  • +5 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Jan 6, 2021

Lymphoblastic Lymphoma Trial in San Diego, Memphis (Prednisone, Vincristine, Daunorubicin)

Completed
  • Lymphoblastic Lymphoma
  • San Diego, California
  • +1 more
Jun 7, 2022

Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial in New York (radiation, drug,

Active, not recruiting
  • Acute Lymphoid Leukemia (ALL)
  • +5 more
  • Hyperfractionated total body irradiation
  • +9 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia Trial in Houston

Recruiting
  • Recurrent Acute Lymphoblastic Leukemia
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 21, 2022

Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,

Completed
  • Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
  • Recurrent Childhood B-Lymphoblastic Lymphoma
  • San Diego, California
  • +2 more
Sep 13, 2022

Acute Lymphoblastic Leukemia Trial in La Jolla, San Diego (Alemtuzumab, Clofarabine)

Terminated
  • Acute Lymphoblastic Leukemia
  • Alemtuzumab
  • Clofarabine
  • La Jolla, California
  • +2 more
Jul 29, 2020

Stem Cell Transplantation, Leukemia, Lymphoma Trial in Houston (Thiotepa, Clofarabine, Busulfan)

Completed
  • Stem Cell Transplantation
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 25, 2020